Jubilant Life Sciences’ unit Jubilant Biosys has received an undisclosed amount as a milestone payment from AstraZeneca for its research on pain management in the neuroscience therapeutic area.
The alliance between Jubilant and London-headquartered drug firm AstraZeneca in the neuroscience therapeutic area began two years ago. Two years collaboration in neuroscience therapeutic area has now expanded to cardiovascular and metabolic diseases and focuses on the delivery of a steady stream of pre-clinical outcomes to AstraZeneca by Jubilant.
AstraZeneca owns the compounds developed under the collaboration with worldwide development and commercialization rights. On the other hand, Jubilant derives research funding and success-based development and commercialization milestone payments.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1882.20 |
| Dr. Reddys Lab | 1290.00 |
| Cipla | 1341.45 |
| Zydus Lifesciences | 944.85 |
| Lupin | 2263.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: